Will New Ratings Coverage by Raymond James Help RadNet (NASDAQ:RDNT) Stock This Week?

March 15, 2018 - By Graig Alexander

 Will New Ratings Coverage by Raymond James Help RadNet (NASDAQ:RDNT) Stock This Week?

Why Has Raymond James Given RadNet (NASDAQ:RDNT) a $15 Price Target

Investment analysts at Raymond James has started coverage on shares of RadNet (NASDAQ:RDNT) in analysts note revealed to investors on Wednesday, 14 March. The financial firm set Strong Buy rating on the stock. Raymond James’s target price of $15 suggests potential of 16.73 % from the stock’s last stock close price.

RadNet, Inc. (NASDAQ:RDNT) Ratings Coverage

Among 4 analysts covering RadNet (NASDAQ:RDNT), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. RadNet has $15 highest and $700 lowest target. $12.67’s average target is -1.40% below currents $12.85 stock price. RadNet had 8 analyst reports since March 15, 2016 according to SRatingsIntel. Jefferies maintained the stock with “Buy” rating in Thursday, March 8 report. The firm has “Buy” rating given on Tuesday, August 22 by Jefferies. The company was initiated on Friday, April 15 by Sidoti. The rating was maintained by Jefferies with “Buy” on Thursday, November 9. The stock of RadNet, Inc. (NASDAQ:RDNT) earned “Neutral” rating by Sterne Agee CRT on Thursday, June 2. Jefferies maintained RadNet, Inc. (NASDAQ:RDNT) on Thursday, July 13 with “Hold” rating. As per Tuesday, March 15, the company rating was maintained by Jefferies.

The stock decreased 0.77% or $0.1 during the last trading session, reaching $12.85. About 119,038 shares traded. RadNet, Inc. (NASDAQ:RDNT) has risen 53.92% since March 15, 2017 and is uptrending. It has outperformed by 37.22% the S&P500.

Analysts await RadNet, Inc. (NASDAQ:RDNT) to report earnings on May, 9. They expect $0.04 EPS, up 500.00 % or $0.05 from last year’s $-0.01 per share. RDNT’s profit will be $1.90M for 80.31 P/E if the $0.04 EPS becomes a reality. After $0.13 actual EPS reported by RadNet, Inc. for the previous quarter, Wall Street now forecasts -69.23 % negative EPS growth.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company has market cap of $611.97 million. The Company’s services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology , fluoroscopy, and other related procedures, as well as multi-modality imaging services. It has a 12850 P/E ratio. The firm also develops and sells computerized systems for the imaging industry, including picture archiving communications systems; and provides teleradiology services for remote interpretation of images on behalf of radiology groups, hospitals, and imaging center customers.

More recent RadNet, Inc. (NASDAQ:RDNT) news were published by: Globenewswire.com which released: “The Cancer Research Collaboration and Breastlink New York Partner With …” on March 15, 2018. Also Globenewswire.com published the news titled: “RadNet, Inc. Announces Date of its Fourth Quarter 2017 Financial Results …” on February 28, 2018. Streetinsider.com‘s news article titled: “Form 4 RadNet, Inc. For: Mar 14 Filed by: Murdock Michael N” with publication date: March 14, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.